|
2,120
|
| 17378 |
biofilm formation
|
|
increases_activity of
|
antibiotic resistance
|
in P.aeruginosa
|
|
10922036
|
Pseudomonas aeruginosa diseases
|
|
2,123
|
| 17448 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
| 17558 |
Acyl-HSL quorum sensing
|
NOT |
affects_quantity of
|
(alginate)n
|
in P. aeruginosa infected patients with CF
|
| 40196 |
(alginate)n
|
|
increases_activity of
|
biofilm formation
|
in patients with CF
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,242
|
| 19106 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelA
|
|
| 19113 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelB
|
|
| 19114 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelC
|
|
| 19116 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelD
|
|
| 19117 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelE
|
|
| 19118 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelF
|
|
| 19120 |
Acyl-HSL quorum sensing
|
|
affects_expression of
|
pelG
|
|
| 19121 |
pelA
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19125 |
pelB
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19126 |
pelC
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19128 |
pelD
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19129 |
pelE
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19130 |
pelF
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19131 |
pelG
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 19132 |
pel-exopolysaccharide
|
|
increases_activity of
|
biofilm formation
|
|
|
19196266
|
Pseudomonas aeruginosa diseases
|
|
2,285
|
| 19591 |
ppyR
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
|
20738404
|
Pseudomonas aeruginosa diseases
|
|
2,586
|
| 24373 |
(alginate)n
|
|
increases_quantity of
|
mucoid strain
|
in patients witn CF
|
| 24375 |
algU
|
|
increases_quantity of
|
(alginate)n
|
|
| 24376 |
mucA
|
|
decreases_quantity of
|
(alginate)n
|
|
|
21833328
|
Pseudomonas aeruginosa diseases
|
|
2,592
|
| 24475 |
rsmA
|
|
decreases_quantity of
|
pel-exopolysaccharide
|
|
| 24476 |
pel-exopolysaccharide
|
|
increases_activity of
|
biofilm formation
|
|
| 30043 |
rsmA
|
|
decreases_quantity of
|
psl-exopolysaccharide
|
|
| 30044 |
psl-exopolysaccharide
|
|
increases_activity of
|
biofilm formation
|
|
|
21955777
|
Pseudomonas aeruginosa diseases
|
|
2,853
|
| 26282 |
kinB
|
|
affects_quantity of
|
(alginate)n
|
|
|
21515773
|
Pseudomonas aeruginosa diseases
|
|
3,206
|
| 29687 |
algU
|
|
increases_expression of
|
algR
|
|
| 29688 |
algU
|
|
increases_quantity of
|
(alginate)n
|
|
| 29689 |
algR
|
|
increases_quantity of
|
(alginate)n
|
|
| 29690 |
mucA
|
|
decreases_quantity of
|
(alginate)n
|
|
| 29698 |
cdiGMP
|
|
increases_quantity of
|
(alginate)n
|
if c-di-GMP level is high
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
|
3,220
|
| 29738 |
cdrA
|
|
interacts (colocalizes) with
|
psl-exopolysaccharide
|
|
|
20088866
|
Pseudomonas aeruginosa diseases
|
|
3,226
|
| 29763 |
(alginate)n
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
|
20300602
|
Pseudomonas aeruginosa diseases
|
|
3,227
|
| 29772 |
tpbB
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 29778 |
small colony variants, SCVs
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 30045 |
tpbB
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 30046 |
small colony variants, SCVs
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
|
20300602
|
Pseudomonas aeruginosa diseases
|
|
3,354
|
| 30776 |
psl-exopolysaccharide
|
|
decreases_activity of
|
opsonization
|
by human innate immune cells
|
| 30777 |
psl-exopolysaccharide
|
|
decreases_activity of
|
complement activation
|
on the P. aeruginosa surface
|
| 30778 |
non-mucoid strain
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 30779 |
psl-exopolysaccharide
|
|
decreases_activity of
|
phagocytosis
|
|
|
21951860
|
Pseudomonas aeruginosa diseases
|
|
3,371
|
| 31007 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
| 31008 |
(alginate)n
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
| 31012 |
small colony variants, SCVs
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31013 |
small colony variants, SCVs
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31014 |
algD
|
|
increases_quantity of
|
(alginate)n
|
|
| 31212 |
alg8
|
|
increases_quantity of
|
(alginate)n
|
|
| 31213 |
alg44
|
|
increases_quantity of
|
(alginate)n
|
|
| 31215 |
algK
|
|
increases_quantity of
|
(alginate)n
|
|
| 31216 |
algE
|
|
increases_quantity of
|
(alginate)n
|
|
| 31217 |
algG
|
|
increases_quantity of
|
(alginate)n
|
|
| 31220 |
algX
|
|
increases_quantity of
|
(alginate)n
|
|
| 31221 |
algL
|
|
increases_quantity of
|
(alginate)n
|
|
| 31222 |
algI
|
|
increases_quantity of
|
(alginate)n
|
|
| 31223 |
algJ
|
|
increases_quantity of
|
(alginate)n
|
|
| 31224 |
algF
|
|
increases_quantity of
|
(alginate)n
|
|
| 31225 |
algA
|
|
increases_quantity of
|
(alginate)n
|
|
| 31226 |
algC
|
|
increases_quantity of
|
(alginate)n
|
|
| 31244 |
algC
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31343 |
L-Guluronic acid
|
|
is_part_of
|
(alginate)n
|
|
| 31344 |
D-Mannuronate
|
|
is_part_of
|
(alginate)n
|
|
| 31345 |
pelA
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31346 |
pelB
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31347 |
pelC
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31348 |
pelD
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31349 |
pelE
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31350 |
pelF
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31351 |
pelG
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31352 |
lipid carrier independent biosynthetic mechanism
|
|
increases_quantity of
|
(alginate)n
|
|
| 31353 |
lipid carrier independent biosynthetic mechanism
|
|
increases_quantity of
|
pel-exopolysaccharide
|
|
| 31370 |
pelD
|
|
interacts (colocalizes) with
|
cdiGMP
|
|
| 31372 |
alg44
|
|
interacts (colocalizes) with
|
cdiGMP
|
|
|
21991261
|
Pseudomonas aeruginosa diseases
|
|
3,372
|
| 31354 |
Mannose
|
|
is_part_of
|
psl-exopolysaccharide
|
|
| 31355 |
L-Rhamnose
|
|
is_part_of
|
psl-exopolysaccharide
|
|
| 31356 |
Glucose
|
|
is_part_of
|
psl-exopolysaccharide
|
|
| 31357 |
lipid carrier dependent biosynthetic mechanism
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31358 |
pslA
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31359 |
pslB
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31360 |
pslC
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31361 |
pslD
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31362 |
pslE
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31363 |
pslF
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31364 |
pslG
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31365 |
pslH
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31366 |
pslI
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31367 |
pslJ
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31368 |
pslK
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
| 31369 |
pslL
|
|
increases_quantity of
|
psl-exopolysaccharide
|
|
|
21991261
|
Pseudomonas aeruginosa diseases
|
|
3,827
|
| 38285 |
mucA
|
|
decreases_activity of
|
algU
|
|
| 38289 |
algU
|
|
increases_expression of
|
algD
|
|
| 38290 |
algU
|
|
increases_expression of
|
alg8
|
|
| 38292 |
algU
|
|
increases_expression of
|
alg44
|
|
| 38293 |
algU
|
|
increases_expression of
|
algK
|
|
| 38294 |
algU
|
|
increases_expression of
|
algE
|
|
| 38296 |
algU
|
|
increases_expression of
|
algG
|
|
| 38299 |
algU
|
|
increases_expression of
|
algX
|
|
| 38300 |
algU
|
|
increases_expression of
|
algL
|
|
| 38301 |
algU
|
|
increases_expression of
|
algI
|
|
| 38304 |
algU
|
|
increases_expression of
|
algJ
|
|
| 38305 |
algU
|
|
increases_expression of
|
algF
|
|
| 38307 |
algU
|
|
increases_expression of
|
algA
|
|
| 38318 |
mucB
|
|
decreases_activity of
|
algU
|
|
| 38321 |
mucB
|
|
interacts (colocalizes) with
|
mucA
|
|
| 38323 |
mucD
|
|
decreases_activity of
|
algU
|
|
| 38326 |
(alginate)n
|
|
increases_activity of
|
antibiotic resistance
|
|
| 38328 |
(alginate)n
|
|
decreases_activity of
|
phagocytosis
|
|
| 38345 |
Cycloserine
|
|
increases_activity of
|
algU
|
|
| 38346 |
Cycloserine
|
|
decreases_activity of
|
mucA
|
|
| 38349 |
algW
|
|
decreases_quantity of
|
mucA
|
|
| 38381 |
algW
|
|
increases_quantity of
|
(alginate)n
|
|
| 38383 |
mucE
|
|
increases_activity of
|
algW
|
|
| 38388 |
mucB
|
|
decreases_activity of
|
algW
|
|
| 38391 |
mucP
|
|
decreases_quantity of
|
mucA
|
|
| 38398 |
mucD
|
|
affects_quantity of
|
mucA
|
|
| 38402 |
clpP
|
|
interacts (colocalizes) with
|
clpX
|
|
| 38403 |
clpP
|
|
decreases_quantity of
|
mucA
|
|
| 38404 |
clpX
|
|
decreases_quantity of
|
mucA
|
|
| 38406 |
prc
|
|
affects_quantity of
|
mucA
|
|
| 38408 |
mucD
|
|
decreases_quantity of
|
bacterial membrane vesicle, MV
|
|
| 38416 |
algW
|
|
decreases_quantity of
|
bacterial membrane vesicle, MV
|
|
| 38418 |
prc
|
|
decreases_quantity of
|
mucA-mut
|
|
| 38423 |
mucA-mut
|
|
increases_activity of
|
algU
|
|
| 38424 |
mucA-mut
|
|
increases_quantity of
|
(alginate)n
|
|
| 38425 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
mucA-mut
|
|
| 38476 |
kinB
|
|
decreases_quantity of
|
(alginate)n
|
|
| 38483 |
kinB
|
|
decreases_activity of
|
algW
|
|
|
22497280
|
Pseudomonas aeruginosa diseases
|
|
4,252
|
| 43422 |
mucus layer
|
NOT |
affects_quantity of
|
pel-exopolysaccharide
|
in mucoid CF isolate PA2192
|
| 43423 |
mucus layer
|
NOT |
affects_quantity of
|
psl-exopolysaccharide
|
in mucoid CF isolate PA2192
|
|
23143799
|
Pseudomonas aeruginosa diseases
|
|
6,402
|
| 60368 |
P. aeruginosa infection, acute
|
|
increases_activity of
|
biofilm formation
|
as shown on MDCK epithelial cells
|
|
25375398
|
Pseudomonas aeruginosa diseases
|
HoPaCI